Ligand-binding dynamics rewire cellular signaling via estrogen receptor-α

Nature Chemical Biology

Volumn 9, Issue 5, 2013, Pages 326-332

  Srinivasan, Sathish ^a   Nwachukwu, Jerome C ^a   Parent, Alex A ^b   Cavett, Valerie ^a   Nowak, Jason ^a   Hughes, Travis S ^a   Kojetin, Douglas J ^a   Katzenellenbogen, John A ^b   Nettles, Kendall W ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL; DNA; DNA BINDING PROTEIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; GREB1 PROTEIN; LIGAND; PROTEIN TYROSINE KINASE; TAMOXIFEN; UNCLASSIFIED DRUG;

ALLOSTERISM; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; HUMAN; HUMAN CELL; ISOMER; LIGAND BINDING; MEDIATOR; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INDUCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ALLOSTERIC REGULATION; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; HEK293 CELLS; HUMANS; LIGANDS; MCF-7 CELLS; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; MOLECULAR STRUCTURE; SIGNAL TRANSDUCTION;

EID: 84879115207     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.1214     Document Type: Article

References (50)

1. Hilser, V.J., Wrabl, J.O. & Motlagh, H.N. Structural and energetic basis of allostery. Annu. Rev. Biophys. 41, 585-609 (2012).
2. Carroll, M.J. et al. Evidence for dynamics in proteins as a mechanism for ligand dissociation. Nat. Chem. Biol. 8, 246-252 (2012).
3. Shiau, A.K. et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95, 927-937 (1998).
4. Nettles, K.W. et al. CBP Is a dosage-dependent regulator of nuclear factor-κB suppression by the estrogen receptor. Mol. Endocrinol. 22, 263-272 (2008).
5. Bruning, J.B. et al. Coupling of receptor conformation and ligand orientation determine graded activity. Nat. Chem. Biol. 6, 837-843 (2010).
6. Hughes, T.S. et al. Ligand and receptor dynamics contribute to the mechanism of graded PPARγ agonism. Structure 20, 139-150 (2012).
7. Carroll, M.J. et al. Direct detection of structurally resolved dynamics in a multiconformation receptor-ligand complex. J. Am. Chem. Soc. 133, 6422-6428 (2011).
8. Shang, Y., Hu, X., DiRenzo, J., Lazar, M.A. & Brown, M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103, 843-852 (2000).
9. Meijsing, S.H. et al. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 324, 407-410 (2009).
10. McInerney, E.M. & Katzenellenbogen, B.S. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen-and estradiol-dependent transcription activation. J. Biol. Chem. 271, 24172-24178 (1996).
11. Nettles, K.W. & Greene, G.L. Ligand control of coregulator recruitment to nuclear receptors. Annu. Rev. Physiol. 67, 309-333 (2005).
12. Darimont, B.D. et al. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12, 3343-3356 (1998).
13. Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H. & Moras, D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 375, 377-382 (1995).
14. Xu, H.E. et al. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα. Nature 415, 813-817 (2002).
15. Nettles, K.W. et al. Structural plasticity in the oestrogen receptor ligand-binding domain. EMBO Rep. 8, 563-568 (2007); erratum 8, 610 (2007).
16. Chadwick, C.C. et al. Identification of pathway-selective estrogen receptor ligands that inhibit NF-κB transcriptional activity. Proc. Natl. Acad. Sci. USA 102, 2543-2548 (2005).
17. Nettles, K.W. et al. Allosteric control of ligand selectivity between estrogen receptors α and β: implications for other nuclear receptors. Mol. Cell 13, 317-327 (2004).
18. Laughlin, J.D. et al. Structural mechanisms of allostery and autoinhibition in JNK family kinases. Structure 20, 2174-2184 (2012).
19. Shang, Y. & Brown, M. Molecular determinants for the tissue specificity of SERMs. Science 295, 2465-2468 (2002).
20. Sicheri, F. & Kuriyan, J. Structures of Src-family tyrosine kinases. Curr. Opin. Struct. Biol. 7, 777-785 (1997).
21. Heery, D.M., Kalkhoven, E., Hoare, S. & Parker, M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387, 733-736 (1997).
22. Berry, M., Metzger, D. & Chambon, P. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9, 2811-2818 (1990).
23. Pham, T.A. et al. Antiestrogen can establish nonproductive receptor complexes and alter chromatin structure at target enhancers. Proc. Natl. Acad. Sci. USA 88, 3125-3129 (1991).
24. Lupien, M. et al. Raloxifene and ICI182,780 increase estrogen receptor-α association with a nuclear compartment via overlapping sets of hydrophobic amino acids in activation function 2 helix 12. Mol. Endocrinol. 21, 797-816 (2007).
25. Planas-Silva, M.D., Shang, Y., Donaher, J.L., Brown, M. & Weinberg, R.A. AIB1 enhances estrogen-dependent induction of cyclin D1 expression. Cancer Res. 61, 3858-3862 (2001).
26. Xu, J., Wu, R.C. & O'Malley, B.W. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat. Rev. Cancer 9, 615-630 (2009).
27. Rae, J.M. et al. GREB 1 is a critical regulator of hormone dependent breast cancer growth. Breast Cancer Res. Treat. 92, 141-149 (2005).
28. Eeckhoute, J., Carroll, J.S., Geistlinger, T.R., Torres-Arzayus, M.I. & Brown, M. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes Dev. 20, 2513-2526 (2006).
29. Wang, Y.H. et al. Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo. Breast Cancer Res. 7, R220-R228 (2005).
30. Wang, C. et al. Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor. Mol. Endocrinol. 25, 1527-1538 (2011).
31. Powell, E. et al. Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERα and ERβ. PLoS ONE 7, e30993 (2012).
32. Rae, J.M. et al. GREB1 is a novel androgen-regulated gene required for prostate cancer growth. Prostate 66, 886-894 (2006).
33. Loven, M.A., Likhite, V.S., Choi, I. & Nardulli, A.M. Estrogen response elements alter coactivator recruitment through allosteric modulation of estrogen receptor β conformation. J. Biol. Chem. 276, 45282-45288 (2001).
34. Hall, J.M., McDonnell, D.P. & Korach, K.S. Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. Mol. Endocrinol. 16, 469-486 (2002).
35. Wang, J.C. et al. Novel arylpyrazole compounds selectively modulate glucocorticoid receptor regulatory activity. Genes Dev. 20, 689-699 (2006).
36. Bapat, A.R. & Frail, D.E. Full-length estrogen receptor α and its ligand-binding domain adopt different conformations upon binding ligand. J. Steroid Biochem. Mol. Biol. 86, 143-149 (2003).
37. Kong, E.H. et al. Delineation of a unique protein-protein interaction site on the surface of the estrogen receptor. Proc. Natl. Acad. Sci. USA 102, 3593-3598 (2005).
38. Chandra, V. et al. Structure of the intact PPAR-γ-RXR-nuclear receptor complex on DNA. Nature 456, 350-356 (2008).
39. Rochel, N. et al. Common architecture of nuclear receptor heterodimers on DNA direct repeat elements with different spacings. Nat. Struct. Mol. Biol. 18, 564-570 (2011).
40. Likhite, V.S., Cass, E.I., Anderson, S.D., Yates, J.R. & Nardulli, A.M. Interaction of estrogen receptor α with 3-methyladenine DNA glycosylase modulates transcription and DNA repair. J. Biol. Chem. 279, 16875-16882 (2004).
41. Nwachukwu, J.C. & Nettles, K.W. The nuclear receptor signalling scaffold: insights from full-length structures. EMBO J. 31, 251-253 (2012).
42. Schultz-Norton, J.R., Ziegler, Y.S. & Nardulli, A.M. ERα-associated protein networks. Trends Endocrinol. Metab. 22, 124-129 (2011).
43. Hammes, S.R. & Levin, E.R. Minireview: recent advances in extranuclear steroid receptor actions. Endocrinology 152, 4489-4495 (2011).
44. Zhan, Y.Y. et al. The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK. Nat. Chem. Biol. 8, 807-904 (2012).
45. Sun, Z. et al. Inhibition of β-catenin signaling by nongenomic action of orphan nuclear receptor Nur77. Oncogene 31, 2653-2667 (2012).
46. National Research Council (U.S.). A New Biology for the 21st Century (eds. Connelly, T. & Sharp, P.) 12 (National Academies Press, Washington, D.C., 2009).
47. Adams, P.D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213-221 (2010).
48. Schüttelkopf, A.W. & van Aalten, D.M. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. D Biol. Crystallogr. 60, 1355-1363 (2004).
49. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132 (2004).
50. McNicholas, S., Potterton, E., Wilson, K.S. & Noble, M.E. Presenting your structures: the CCP4mg molecular-graphics software. Acta Crystallogr. D Biol. Crystallogr. 67, 386-394 (2011).